ASX - By Stock
|
EBR |
FDA submission and looming approval
|
|
Wanderdog
|
0 |
347 |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
0
|
347
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
24 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.7M
|
24
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
Wanderdog
|
390 |
137K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
390
|
137K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO
|
|
Wanderdog
|
112 |
45K |
10 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
112
|
45K
|
10
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
Wanderdog
|
338 |
87K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
338
|
87K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX became a Top 100 ASX company
|
|
Wanderdog
|
36 |
21K |
16 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
36
|
21K
|
16
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra US Sales Curve
|
|
Wanderdog
|
29 |
18K |
19 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
29
|
18K
|
19
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
11 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
10K
|
3.7M
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Wanderdog
|
190 |
65K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
65K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
Wanderdog
|
190 |
65K |
13 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
190
|
65K
|
13
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Reports Q1 2024 Financial Performance
|
|
Wanderdog
|
61 |
26K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
61
|
26K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
17 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
196
|
72K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
17 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
196
|
72K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
11 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
196
|
72K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
23 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
196
|
72K
|
23
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
12 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
196
|
72K
|
12
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
20 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
196
|
72K
|
20
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
Wanderdog
|
196 |
72K |
18 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
196
|
72K
|
18
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wanderdog
|
14K |
5.1M |
14 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
14K
|
5.1M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wanderdog
|
14K |
5.1M |
12 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
14K
|
5.1M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
30 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
10K
|
3.7M
|
30
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
15 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
10K
|
3.7M
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wanderdog
|
14K |
5.1M |
15 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
14K
|
5.1M
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Wanderdog
|
239 |
68K |
16 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
68K
|
16
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
7 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
7
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
Wanderdog
|
342 |
113K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
342
|
113K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
27 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
10K
|
3.7M
|
27
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
16 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
10K
|
3.7M
|
16
|
|
ASX - By Stock
|
OPT |
Re:
Opthea shares target raised on trial progress
|
|
Wanderdog
|
32 |
10K |
7 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
32
|
10K
|
7
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
Wanderdog
|
342 |
113K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
342
|
113K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Opthea shares target raised on trial progress
|
|
Wanderdog
|
32 |
10K |
4 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
3 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
Wanderdog
|
342 |
113K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
342
|
113K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of QSAM
|
|
Wanderdog
|
5 |
2.3K |
8 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
5
|
2.3K
|
8
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
7 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.3K
|
669K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Wanderdog
|
43 |
13K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
43
|
13K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Wanderdog
|
636 |
227K |
22 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
636
|
227K
|
22
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wanderdog
|
14K |
5.1M |
13 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
14K
|
5.1M
|
13
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
Wanderdog
|
153 |
63K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
153
|
63K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra - Post approval royalties, costs and earnings
|
|
Wanderdog
|
31 |
13K |
22 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
31
|
13K
|
22
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Wanderdog
|
10K |
3.7M |
18 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
10K
|
3.7M
|
18
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.3K
|
669K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Wanderdog
|
1.3K |
669K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.3K
|
669K
|
8
|
|
ASX - By Stock
|
BDT |
Re:
New camera series
|
|
Wanderdog
|
9 |
1.7K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
9
|
1.7K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Wanderdog
|
100 |
29K |
30 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
100
|
29K
|
30
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Wanderdog
|
161 |
77K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
161
|
77K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
Wanderdog
|
161 |
77K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
161
|
77K
|
9
|
|